settlement Quidel, Beckman Coulter Settle Legal Dispute Over Cardiac Immunoassay Business The firms have agreed to transition the business to Beckman, with Quidel receiving annual payments until 2029. Cancer Genetics Settles Failed Merger Deal With NovellusDx; Receives $6M From Interpace Cancer Genetics announced its planned merger with NovellusDx in September 2018, but scuttled the deal with the Israeli company a few months later. 10x Genomics to Pay $25M, Cross-License Patents to End BD Infringement Suit 10x will pay Becton Dickinson $25 million over four years and the firms have agreed to refrain from engaging in a legal battle on other fronts. PacBio, Oxford Nanopore Settle Patent Dispute in Europe Under the terms of the agreement, Oxford Nanopore Technologies will not sell its 2D sequencing products in the UK and in Germany for five years. Biotheranostics Settles False Claims Allegations With DOJ for $2M The DOJ alleged Biotheranosics promoted and performed its Breast Cancer Index test for patients who had not been in remission for five years and who had not been taking tamoxifen. Sep 28, 2017 Alere Settles With SEC for $13M Nov 29, 2016 Med BioGene, Helomics Revise Licensing Agreement Jul 22, 2015 Enzo, Siemens Resolve IP Infringement Case Feb 9, 2015 Myriad Settles BRCA Patent Case with Quest; Only GeneDx Lawsuit Remains Sep 17, 2014 CareDx Settles with Roche Over Allegations of Breach of Agreement Nov 15, 2012 Alnylam, Tekmira End Litigation with $65M Settlement Premium May 9, 2012 Genetic Technologies, GeneSeek Settle Patent Dispute May 2, 2012 Pacific Biosciences Settles IP Litigation with Life Technologies, Helicos Apr 30, 2012 Vermillion, Bio-Rad Settle Claims Stemming from Sale of Proteomics Technology Mar 7, 2012 Affymetrix Completes Repurchase of $92M of Senior Notes as Part of Settlement Feb 14, 2012 Vermillion Receives $1M in Settlement; Moves to Nasdaq Capital Market Feb 6, 2012 Genetic Technologies, Eurofins STA Labs Settle Infringement Dispute Dec 1, 2011 GTG Settles Dispute, Licenses Technology to AutoImmun Nov 28, 2011 Rosetta Defaults on Payment to Prometheus, Warns of Potential Bankruptcy Protection Oct 27, 2011 Caliper Settles Shareholder Lawsuits Tied to Acquisition by PerkinElmer Jul 21, 2011 GE Healthcare, Beckman Coulter Settle Nucleic Acid Sample Prep Lawsuit Premium May 17, 2011 U of Washington, Pharmigene Resolve IP Dispute, Reach Licensing Deal Dec 2, 2010 Rosetta Regains US Rights to miRNA Cancer Diagnostics, Addresses QC Issue at Diagnostics Lab Premium Nov 23, 2010 Rosetta, Prometheus Settle Arbitration on MicroRNA Tests Breaking News In Brief This Week: Illumina, Personalis, Proteomedix, and More Ancient DNA Details Population Dynamics Within Andean Tiwanaku Civilization Genomic Data Spanning 2K Years Gives Glimpse of Etruscan Origins, Population Changes People in the News: New Appointments at Hologic, Akoya Biosciences, Caris Life Sciences, More At NSGC, Genetic Counselors Address Race-Based Medicine, Ways to Change New Products Posted to GenomeWeb: Becton Dickinson, Cosmos-ID, OncoDNA, More The Scan US Booster Eligibility Decision The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions. Arizona Bill Before Judge The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction. Additional Genes Wales is rolling out new genetic testing service for cancer patients, according to BBC News. Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.